Underestimation of cost of hepatitis B vaccine in India
Agarwal, K.
Indian journal of gastroenterology official journal of the Indian Society of Gastroenterology 21(2): 87; author reply 87
2002
ISSN/ISBN: 0254-8860 PMID: 11990343 Document Number: 541181
Document emailed within 1 workday
Related Documents
Sachdev, P.; Sehgal, A.; Puliyel, J. 2001: Underestimation of cost of hepatitis B vaccination in India Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 20(5): 205-206Aspinall, S.; Kocks, D.J. 1998: Immunogenicity of a low-cost hepatitis B vaccine in the South African Expanded Programme on Immunisation South African Medical Journal 88(1): 36-39
Rieger, M.A.; Hasselhorn, H.M.; Beie, M.; Kralj, N.; Vetter, H.D.; Hofmann, F. 2001: Personnel-to-patient transmission of hepatitis C virus: underestimation of exposure Archives of Internal Medicine 161(7): 1017-1018
Verma, R.; Khanna, P. 2012: Hepatitis A vaccine should receive priority in National Immunization Schedule in India Human Vaccines and Immunotherapeutics 8(8): 1132-1134
Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616
Bravo, L.; Carlos, J.; Gatchalian, S.; Borja-Tabora, C.; Bibera, G.; Willems, P.; Safary, A.; Bock, H.L. 1998: The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth Southeast Asian Journal of Tropical Medicine and Public Health 29(4): 772-778
Hudecková, H.; Straka, S.; Szilágyiová, M.; Avdicová, M.; Rusnáková, S. 2002: Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic Central European Journal of Public Health 10(4): 146-148
Akahane, Y. 1981: Development of research on B-type hepatitis virus vaccine---including HBs antigen polypeptide vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 39(3): 619-630
John, T.J. 1996: Vaccine stability in the context of vaccine delivery in a developing country: India Developments in Biological Standardization 87: 19-25
Faingezicht, I.; Avila-Aguerro, M.L.; Cervantes, Y.; Fourneau, M.; Clemens, S.A.C. 2002: Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Revista Panamericana de Salud Publica 12(4): 247-257
Hu, Z.; Teng, H.; Han, M. 1994: Observation on prevention of hepatitis B virus transmission from mother to baby by hepatitis B vaccine Zhonghua Liu Xing Bing Xue Za Zhi 15(6): 346-348
McIntyre, A.; Nimmo, G.R.; Wood, G.M.; Tinniswood, R.D.; Kerlin, P. 1992: Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause? Australian and New Zealand Journal of Medicine 22(1): 19-22
Inskip, H.M.; Hall, A.J.; Temple, I.K.; Loik, F.; Herbage, E.; Chotard, J.; Whittle, H. 1991: Response to hepatitis B vaccine in relation to the hepatitis B status of family members International Journal of Epidemiology 20(3): 770-773
Curciarello, J.O.; Corallini, O.; Adrover, R.E.; Chiera, A.O.; Giammona, A.M.; Barbero, R.; Apraiz, M.; Belloni, P.O.; Neumann, M.; Jmelnitzky, A.C. 1994: Viral hepatitis infection and response to the hepatitis B vaccine in hemodialyzed patients Acta Gastroenterologica Latinoamericana 25(5): 291-296
Liu, K.Z. 1989: A preliminary study on response to hepatitis B vaccine in subjects with various levels of antibody to hepatitis B surface antigen Zhonghua Yu Fang Yi Xue Za Zhi 23(3): 132-134
Zhang, S.X. 1992: Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis Zhonghua Yu Fang Yi Xue Za Zhi 26(3): 154-158
Woodruff, B.A.; Stevenson, J.; Yusuf, H.; Kwong, S.L.; Todoroff, K.P.; Hadler, J.L.; Hoyt, M.A.; Mahoney, F.J. 1996: Progress toward integrating hepatitis B vaccine into routine infant immunization schedules in the United States, 1991 through 1994. Connecticut Hepatitis B Project Group Pediatrics 97(6 Part 1): 798-803
Sunthornchart, S.; Linkins, R.W.; Natephisarnwanish, V.; Levine, W.C.; Maneesinthu, K.; Lolekha, R.; Tappero, J.W.; Trirat, N.; Muktier, S.; Chancharastong, P.; Fox, K.; Donchalermpak, S.; Vitek, C.; Supawitkul, S. 2008: Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005 Addiction 103(10): 1687-1695
Lim, F.Seng.; Han, H-Htay.; Jacquet, J-Marie.; Bock, H.L. 2007: Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine Annals of the Academy of Medicine Singapore 36(10): 801-806